Published May 2017 | Version v1
Journal article Metadata-only

Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5 × 6 Gy) conformal radiotherapy

Creators

  • 1. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York (United States)
  • 2. Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York (United States)
  • 3. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York (United States)

Description

Background and purpose: Hypofractionated conformal radiotherapy (hfCRT) is used for larger brain metastases or metastases near critical structures. We investigated hfCRT outcomes for newly diagnosed brain metastases.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2017.03.018

Additional details

Identifiers

DOI
10.1016/j.radonc.2017.03.018;
PII
S0167814017301299;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
123
Journal Issue
2
Journal Page Range
p. 203-208
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50081011
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRAIN; DIAGNOSIS; METASTASES; PATIENTS; RADIOTHERAPY
Descriptors DEC
BODY; CENTRAL NERVOUS SYSTEM; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.